Massivemarkets

ABEO

Abeona Therapeutics Inc. Common Stock

Nasdaq · usd

$4.40-0.07 (-1.57%)
As of 7:30:04 PM EDT on Oct 23, 2026 · 15-minute delayed

Abeona Therapeutics Inc. Common Stock (ABEO) trades at $4.40 (-1.57%) as of 7:30:04 PM EDT on Oct 23, 2026, -18.97% over the past month. Market cap is $255.61M, with 11.6 days to cover in short interest.

Stock performance

How Abeona Therapeutics Inc. Common Stock (ABEO) stock has performed from one day to one year, with its 52-week range.

-0.11%
-$0.00 over 1D
$4.30$4.34$4.38$4.424:05 AM11:05 AM12:45 PM2:20 PM8:00 PM$4.41
1D
-1.57%
1W
-0.68%
1M
-18.97%
YTD
-16.51%
1Y
-20.58%
52-wk range
$4.00 – $7.65

Key statistics

Today's trading snapshot for ABEO: day range, open, previous close, volume and market cap.

Day range
$4.29 – $4.44
Open
$4.42
Prev close
$4.47
Volume
780.95K
Market cap
$255.61M
Shares out
57.18M

Valuation and profitability ratios: P/E, P/S, ROE

Valuation and profitability ratios for Abeona Therapeutics Inc. Common Stock: P/E, P/S, P/B, ROE and more.

P/E
—
P/S
10.02
P/B
2.00
P/FCF
—
ROE
-49.1%
ROA
-35.0%
Debt/Equity
0.12
Div yield
0.00%

As of Oct 22, 2026

8-K filings

Material corporate events Abeona Therapeutics Inc. Common Stock has disclosed to the SEC on Form 8-K.

  • Investor communicationsSep 15, 2026

    Abeona Therapeutics Inc. is furnishing in this Current Report on Form 8-K an updated investor presentation (the "Investor Presentation") that it expects to use, either in whole or in part, on September 15, 2026 at the H.C. Wainwright 28th Annual Global Investment Conference.

  • Equity activityJun 12, 2026

    A proposal to an increase in the number of shares reserved for issuance under the Second Amended and Restated Abeona Therapeutics Inc. 2023 Equity Incentive Plan from 8,400,000 to 11,500,000 was approved by the following votes: Votes For 23,975,061 Votes Against 5,720,643 Abstentions 33,357

  • Board of directorsJun 12, 2026

    On June 11, 2026, Michael Amoroso resigned as a member of the Board of Directors (the "Board") of Abeona Therapeutics Inc. (the "Company") effective immediately. In connection with his resignation, Mr. Amoroso also resigned from the Nominating and Corporate Governance Committee of the Board on which he served. Mr. Amoroso's resignation was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices but solely for personal reasons.

  • Investor communicationsJun 10, 2026

    Abeona Therapeutics Inc. is furnishing in this Current Report on Form 8-K an updated investor presentation (the "Investor Presentation") that it expects to use, either in whole or in part, in connection with presentations to investors, analysts, and others.

  • Board of directorsApr 7, 2026

    On April 1, 2026, the Board of Directors (the "Board") of Abeona Therapeutics Inc. (the "Company"), acting upon the recommendation of its Nominating and Corporate Governance Committee, expanded the size of the Board from nine to ten members and appointed Keith A. Goldan as a member of the Board of the Company as a Class 1 director. Mr. Goldan will serve on the Board for a term expiring at the Company's 2026 annual meeting of stockholders. The Board also appointed Mr. Goldan to serve as Chair of the Audit Committee.

Dividend history and stock splits

Abeona Therapeutics Inc. Common Stock's recent dividend payments and stock splits.

Dividends

No recent dividends.

Splits

  • 1-for-25Jul 5, 2022

ABEO short interest

How heavily ABEO is shorted: shares short, days to cover and average daily volume.

Days to cover
11.6
Short interest
16.88M
Avg volume
1.46M

As of · reported to FINRA twice monthly.

ABEO news

The latest news and headlines about Abeona Therapeutics Inc. Common Stock (ABEO).

Frequently asked questions

What is the Abeona Therapeutics Inc. Common Stock (ABEO) stock price today?

Abeona Therapeutics Inc. Common Stock (ABEO) is trading at $4.40 (-1.57% on the day) as of 7:30:04 PM EDT on Oct 23, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

What is Abeona Therapeutics Inc. Common Stock?

Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of…

What is the short interest in ABEO?

As of Sep 30, 2026, ABEO has 16.88M shares short and 11.6 days to cover.

What exchange is ABEO listed on?

Abeona Therapeutics Inc. Common Stock (ABEO) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.

Build with AI

Build an analysis of ABEO with your agent

Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.

Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a ABEO analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.

Want the most up-to-date, real-time data? Connect to the Massive API and MCP server — the source behind every number on this page — covering stocks, options, indices, currencies and futures. Docs: https://massive.com/docs/rest. Get a free API key.

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.